Ambrisentan

• Description:

  Ambrisentan (BSF 208075; LU 208075) is a highly selective antagonist of the endothelin-1 type A receptor (ETA) for use in the treatment of pulmonary hypertension.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  378.4211

• Molecular Formula:

  C22H22N2O4

• Notes:

  Research use only, not for human use.

• Receptor:

  ET-A

• CAS Number:

  177036-94-1